As a co-signer to the group letter opposing AB 265 (Wood), MOASC encourages you to oppose this bill being decided in the California Assembly. As you know, AB 265 would ban patients in California from receiving copayment assistance programs from pharmaceutical manufacturers when a therapeutically equivalent or interchangeable brand or generic drug is available at a lower cost.  This is of great concern to MOASC and the patient advocacy community because copay assistance programs are a valuable resource for many patients who may be struggling to afford increasing out of pocket costs with their insurance coverage for medications. For more information click here and go to MOASC News.

The California Medical Association (CMA) is offering a free one-hour webinar on April 12 to members to review the kinds of conversations that are necessary for effective care planning and when to have them. For more information click here and go to California News.

Bladder/Urothelial Tumor Markers Final LCD – Effective May 16, 2017
The following Local Coverage Determination (LCD) has completed the Open Public and Contractor Advisory Committee (CAC) comment period and is now finalized. For more information click here and go to Noridian News.

The Centers for Medicare & Medicaid Services (CMS), yesterday, released final updates to the Medicare Advantage and Part D Prescription Drug Programs for 2018. Through these changes, CMS seeks to support benefit flexibility and efficiency that allows Medicare enrollees to choose the care that best fits their health needs. For more information click here and go to CMS News.

The United States cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to ASCO’s fourth annual State of Cancer Care in America report. The report is published in the Journal of Oncology Practice and was presented at a briefing on Capitol Hill. For more information click here and go to Affiliate Association News.

 

To view the complete California Oncology Weekly Newsletter click on the date below.

April 11, 2017